Next Article in Journal
Antioxidant and Antigenotoxic Activities of the Brazilian Pine Araucaria angustifolia (Bert.) O. Kuntze
Previous Article in Journal
Free Radical Scavenging and Antioxidant Activities of Silymarin Components
Previous Article in Special Issue
Antioxidant Defenses in Plants with Attention to Prunus and Citrus spp.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Biological Activities of Phenolic Compounds of Extra Virgin Olive Oil

Dipartimento di Scienze Economico-Estimative e degli Alimenti, Sezione di Tecnologie e Biotecnologie degli Alimenti, Università degli Studi di Perugia, Via S. Costanzo, Perugia 06126, Italy
Author to whom correspondence should be addressed.
Antioxidants 2014, 3(1), 1-23;
Submission received: 16 October 2013 / Revised: 27 November 2013 / Accepted: 28 November 2013 / Published: 20 December 2013
(This article belongs to the Special Issue Plant Antioxidants)


Over the last few decades, multiple biological properties, providing antioxidant, anti-inflammatory, chemopreventive and anti-cancer benefits, as well as the characteristic pungent and bitter taste, have been attributed to Extra Virgin Olive Oil (EVOO) phenols. In particular, growing efforts have been devoted to the study of the antioxidants of EVOO, due to their importance from health, biological and sensory points of view. Hydrophilic and lipophilic phenols represent the main antioxidants of EVOO, and they include a large variety of compounds. Among them, the most concentrated phenols are lignans and secoiridoids, with the latter found exclusively in the Oleaceae family, of which the drupe is the only edible fruit. In recent years, therefore, we have tackled the study of the main properties of phenols, including the relationships between their biological activity and the related chemical structure. This review, in fact, focuses on the phenolic compounds of EVOO, and, in particular, on their biological properties, sensory aspects and antioxidant capacity, with a particular emphasis on the extension of the product shelf-life.

Graphical Abstract

1. Introduction

Several epidemiological studies have demonstrated that adherence to the Mediterranean diet can be associated with longevity and with a reduced risk of morbidity and mortality [1,2]. The traditional Mediterranean food pattern encompasses a number of dietary components, which are thought to be associated with protective health effects within this nutritional pattern. In this context, Extra Virgin Olive Oil (EVOO) plays an important role as the main source of fats in the diet of this area (Reg EU 432/2012) [3]. EVOO is the fresh olive juice obtained exclusively by mechanical and physical processes. It consists of a major fraction of mono- and poly-unsaturated fatty acids (mainly triacylglycerides) representing more than 98% of the total weight, whereas the minor fraction (approximately 2% of the weight) is composed of a complex set of minor compounds, which includes over 230 chemical compounds (aliphatic and triterpenic alcohols, sterols, hydrocarbons, volatile compounds and antioxidants). Traditionally, the nutritional values of EVOO are due to the high monounsaturated fatty acid (MUFA) content, principally made of oleic acid. This represents the most abundant, monoenoic, fatty acid in olive oil, the concentration of which ranges from 56% to 84% of the total fraction of fatty acids. On the other hand, the linoleic acid concentration (which represents the major, essential, fatty acid and the most abundant, polyunsaturated acid in the Mediterranean diet) ranges between 3% and 21%. Several studies have suggested that MUFAs are effective in reducing LDL-cholesterol activity, even though the associated mechanisms are not well known.
Several studies carried out recently have demonstrated that the healthy effects should also be attributed to the Olive Phenols (OP) of EVOO [4,5,6,7]. According to EFSA (2011), the chemical composition of EVOO and its phenolic fraction in particular is effective in decreasing the risk of cardiovascular disease [3]. Moreover, several studies on EVOO [8] support the fact that the daily consumption of OP, estimated at 5 mg/day, has very important, healthy effects on humans because of the reduction in the peroxidation of blood lipids due to phenols. The main antioxidants in EVOO are represented by lipophilic and hydrophilic phenols [9], with the presence of a small amount of carotenoids. Moreover, lipophilic phenols (especially tocopherols and tocotrienols) can also be found in other vegetable oils. To this regard, over 90% of tocopherols in EVOO is made by α-tocopherol, the concentration of which is also characterized by a strong variation depending on pedoclimatic factors and agronomic practices, such as the area of origin, the cultivar and the stage of fruit ripening [10,11]. The data obtained assessing 430 samples of EVOO have showed a range of variability included between 23 and 751.1 mg/kg.
EVOO hydrophilic phenols represent a class of secondary plant metabolites demonstrating unusual sensory and health properties. Generally speaking, unlike lipophilic phenols, they are not found in other oils and fats [9,12]. The chemical composition of the hydrophilic phenolic fraction of EVOO has been studied extensively in the past. Different groups of phenolic compounds can be found in these olive oils, such as phenolic acids, phenolic alcohols, hydroxy-isochromans, flavonoids, lignans and secoiridoids (Table 1) [4,13,14]. The first groups of phenols discovered in EVOO were phenolic acids, including caffeic, vanillic, syringic, p-coumaric, o-coumaric, protocatechuic, sinapic, p-hydroxybenzoic and gallic acid [4,15,16,17]. In the past, phenolic alcohols, principally represented by (3,4-dihydroxyphenyl)ethanol (3,4-DHPEA) and (p-hydroxyphenyl)ethanol (p-HPEA), were discovered in EVOO. According to Montedoro et al. [16], their concentration is generally low in freshly pressed oils, but this increases during oil storage, as a consequence of the hydrolysis of EVOO secoiridoids, such as 3,4-DHPEA-EDA, p-HPEA-EDA and 3,4-DHPEA-EA, all containing 3,4-DHPEA and p-HPEA residuals (Table 2) [18]. More recently, Rovellini and co-workers [14] identified flavonoids (such as luteolin and apigenin) in EVOO. Another class of chemical compounds found in EVOO are lignans, which include (+)-1-acetoxypinoresinol and (+)-1-pinoresinol (Table 2) [19,20]. These chemical compounds (mainly found in the olive pulp and in the woody portion of the seed) are released in EVOO during the extraction process. Table 2 shows the average concentrations of EVOO (+)-1-acetoxypinoresinol and (+)-1-pinoresinol. A detailed analysis of these values singled out that their concentration in EVOO varies less compared to the concentration of secoiridoids, due to the fact that the extent to which they are found in EVOO depends principally on the agronomic conditions required to cultivate olive trees. On the other hand, the technological parameters adopted during the oil extraction process impact slightly on the concentration of EVOO lignans [5]. A quantitative evaluation on several individual hydrophilic phenols of EVOO was performed by HPLC and the averaged concentrations, expressed as median, of prevalent secoiridoids, phenolic acid and phenolic alcohols of EVOO are reported in Table 2.
Table 1. Phenolic compounds in Extra Virgin Olive Oil (EVOO).
Table 1. Phenolic compounds in Extra Virgin Olive Oil (EVOO).
Phenolic acids and derivatives Phenolic alcohols
Vanillic acid (3,4-Dihdroxyphenyl) ethanol (3,4 DHPEA)
Syringic acid (p-Hydroxyphenil) ethanol (p-HPEA)
p-Coumaric acid (3,4-Diidrossifenil)etanolo-glucoside
o-Coumaric acid
Gallic acid LignansFlavones
Caffeic acid(+)-1-Acetoxypinoresinol Apigenin
Protocatechuic acid (+)-Pinoresinol Luteolin
p-Hydroxybenzoic acid
Ferulic acidHydroxy-isocromans
Cinnamic acid
Benzoic acid
Dialdehydic form of decarboxymethyl elenolic acid linked to 3,4-DHPEA (3,4 DHPEA-EDA)
Dialdehydic form of decarboxymethyl etenolic acid linked to p-HPEA (p-HPEA-EDA)
Oleuropein aglycon (3,4 DHPEA-EA)
Ligstroside aglycon
Dialdehydic form of oleuropein aglycon
Dialdehydic form of ligstroside aglycon
Table 2. Chemical structures and average values (mg/kg) of the prevalent phenolic alcohols, phenolic acids and secoiridoids of EVOO calculated using 210 oil samples obtained in industrial plants a [4].
Table 2. Chemical structures and average values (mg/kg) of the prevalent phenolic alcohols, phenolic acids and secoiridoids of EVOO calculated using 210 oil samples obtained in industrial plants a [4].
ClassCompoundsChemical structureConcentration
MedianLower quintileUpper quintile
Phenolic acidsVanillic acid Antioxidants 03 00001 i0010,200,3
Caffeic acid Antioxidants 03 00001 i0020,40,20,7
Phenolic alcohols(3,4-Dihdroxyphenyl) ethanol (3,4 DHPEA) Antioxidants 03 00001 i0031,813,6
(p-Hydroxyphenyl) ethanol (p-HPEA) Antioxidants 03 00001 i0041,90,65
SecoiridoidsDialdehydic form of decarboxymethyl elenolic acid linked to 3,4-DHPEA (3,4 DHPEA-EDA) Antioxidants 03 00001 i005185,748,2631,1
Dialdehydic form of decarboxymethyl elenolic acid linked to p-HPEA (p-HPEA-EDA) Antioxidants 03 00001 i00636,122,578,8
Oleuropein aglycon (3,4 DHPEA-EA) Antioxidants 03 00001 i007 126,361231
Ligstroside aglycon (p-HPEA-EA) Antioxidants 03 00001 i008n.d.n.d.n.d.
Lignans(+)-1-Acetoxypinoresinol Antioxidants 03 00001 i00924,612,930,8
(+)-1-Pinoresinol Antioxidants 03 00001 i01014,48,847,7
a Unpublished results. The concentration of hydrophilic phenols was evaluated by HPLC as previously reported by Montedoro et al. [16].
As we pointed out before, secoiridoids represent the larger fraction of hydrophilic phenols in EVOO. In particular, their chemical structure is represented by the dialdehydic form of decarboxymethyl elenolic acid linked to 3,4-DHPEA or p-HPEA (3,4-DHPEA-EDA or p-HPEA-EDA), an isomer of oleuropein aglycon (3,4-DHPEA-EA) and ligstroside aglycon (p-HPEA-EA). Montedoro et al. [16,21,22] were the first to identify secoiridoids in olive oil and in 1993, they also associated their related chemical structure. This was further confirmed by other authors [19,23] (Table 1). These compounds (aglycon derivatives of secoiridoid glucosides contained in the olive fruit) are generated during the mechanical extraction process of the oil, by means of the reactions of oleuropein, demethyloleuropein and ligstroside hydrolysis, catalysed by endogenous β-glucosidases [24]. In fact, olives contain a large amount of phenolic compounds, the concentration of which ranges between 1% and 3% of the weight of the fresh pulp [25]. The aforementioned precursor compounds, in particular, are the most abundant secoiridoid glucosides in the olive fruit. On the contrary, hydroxy-isochromans and oleuropein glucoside (with a range of 5–60 µg/kg) are considered as minor hydrophilic phenols of EVOO.
The concentration of phenols in EVOO is strongly affected by agronomic factors, such as the area of origin, the cultivar, the stage of fruit ripening and also by several agronomic procedures and the technological, operative conditions of the oil extraction process [4,5,10,11,26,27,28,29,30,31,32,33,34,35,36,37,38]. As regards the technological aspects, the processing parameters, such as the operative conditions of crushing and malaxation and of the extraction system, are of great importance to determine the oil hydrophilic phenol content [4,5,34,35,36,37]. In many EVOOs, phenolic compounds are usually present in various concentrations, ranging from 50 to 940 mg/kg.
In this perspective, studies involving humans and animals (in vivo and in vitro) have demonstrated that olive oil phenolic compounds have potentially beneficial, biological effects resulting from their antioxidant, antimicrobial and anti-inflammatory activities. This review summarizes the current knowledge of the biological properties and the characteristic pungent and bitter taste of olive oil phenolic compounds. Accordingly, the paper is divided into the following sections: Section 2 discusses the antioxidant activities of phenolic compounds; Section 3 illustrates the effects of hydrophilic phenols on health, and Section 4 considers some of the sensorial aspects.

2. Antioxidant Activities of Hydrophilic Phenols of EVOO

Antioxidants, as already mentioned, play a key role in the shelf life of EVOO due to their biological activity delaying oxidation processes. In this respect, the primary antioxidants inhibiting oxidation processes in EVOO are OP, which act as chain breakers by donating radical hydrogen to alkylperoxyl radicals, produced by lipid oxidation and the formation of stable derivatives during the reaction (Figure 1). Simple phenols, lignans and secoiridoids represent the phenolic fraction of EVOO, and both their antioxidant properties and their antioxidant activities have been extensively studied in the past [4,5]. Most of these studies focused on the relationships between OP and the relative EVOO shelf-life, using the AOM (Active Oxygen Method) and Rancimat [20,39,40] experimental accelerated methods to investigate them. Moreover, the correlation between total phenols, their antioxidant activity and EVOO shelf life (assessed using a colorimetric method on the methanolic extract of EVOO, the ORAC (Oxygen Radical Absorbance Capacity) test and the Rancimat method, respectively) was confirmed very recently [5,41,42].
Figure 1. Mechanism of the antioxidant activity of Olive Phenols (Ops) on EVOO.
Figure 1. Mechanism of the antioxidant activity of Olive Phenols (Ops) on EVOO.
Antioxidants 03 00001 g001
However, the same high antioxidant power of 3,4-DHPEA was also shown in an evaluation of the antioxidant activity of some specific hydrophilic phenols (3,4-DHPEA, p-HPEA and phenolic acids, such as caffeic acid, p-coumaric acid, ferulic acid, syringic acid and vanillic acid) in refined olive oil and in sunflower oil, [4]. Baldioli et al. [39] also investigated this property, with a specific study of the oxidative stability of EVOO in several secoiridoids, which were isolated from EVOO using the Rancimat test. They tested, the resistance to oxidation of some oil samples at a temperature of 120 °C, by exposing them to a flow of dry air. The results obtained indicated that o-diphenols (3,4-DHPEA, 3,4-DHPEA-EDA and 3,4-DHPEA-EA) showed a higher antioxidant activity than p-HPEA and α-tocopherol [39]. These results also confirmed the fact that the natural antioxidants of EVOO with the highest antioxidant efficacy were 3,4-DHPEA and secoiridoids (in particular 3,4-DHPEA-EDA and 3,4-DHPEA-EA previously mentioned) characterized by a molecular structure containing 3,4-DHPEA, and that the antioxidant activity depends on the relative concentrations of these phenols in EVOO.
Artajo et al. [43] also used the Rancimat test in order to study the antioxidant power of secoiridoids. They discovered that the strongest antioxidant effects were observed when 3,4-dihydroxy and 3,4,5-trihydroxy residuals are linked to an aromatic ring, such as oleuropein, 3,4-DHPEA-EDA, and the methylated form of 3,4-DHPEA-EA.
Furthermore, Carrasco-Pancorbo et al. [44] assessed the antioxidant activity of different EVOO polyphenols. In order to carry out the evaluation, they used the DPPH (1,1,-diphenyl-2-picrylhydrazyl) method, the OSI (Oxidative Stability Instrument) and the flow injection analysis (FIA)—amperometry and the electrochemical method in cyclic voltammetry. Thus, they confirmed the possibility that phenols act as hydrogen donors and also demonstrated the fact that oxidation in EVOO is inhibited by an increase in the number of hydroxyl groups in the structure of OPs. In particular, they were able to demonstrate that compounds linked with a o-dihydroxyl functionality had a high antioxidant activity, due to the formation of intramolecular hydrogen bonds observed during the reaction with free radicals. Moreover, the phenol O–H bond is weakened by electron-donating substituents in the “ortho” position and they also stabilize the phenoxyl radical. Therefore, the outcomes of the three aforementioned tests seem to confirm the importance of the hydroxyl groups, which enhance antioxidant activity, as in hydroxytyrosol (3,4-DHPEA), 3,4-DHPEA-EDA, and 3,4-DHPEA-EA, which were found to be the strongest antioxidants. On the other hand, the –COOCH3 fragment, such as in oleuropein aglycon, gives rise to a decrease in the antioxidant capacity due to its inability to act as electron donor [44].
The antioxidant power of lignans was recently studied by Owen et al. [19]. They correlate the radical scavenging ability of the EVOO phenolic extract with a concentration of lignans, although other authors did not recognize the observed antioxidant activity of these phenolic compounds [41,43,44].
In 2007, hydroxytyrosyl acyclodihydroelenolate and p-coumaroyl-6-secologanoside (comselogoside) biophenolic secoiridoids were isolated, purified and structurally identified by Obied et al. [45], in Australian Frantoio olive mill waste (OMW) extracts. Another important feature observed in both biophenolic secoiridoids was that their in vitro DPPH scavenging ability is similar to that of 3,4-DHPEA and oleuropein [46]. In particular, hydroxytyrosol acylclodihydroelenolate was revealed to be more effective in the radical scavenging process than 3,4-DHPEA and oleuropein, due to its linear structure making the sterically hindered DPPH radical more accessible. More recently, Angelino et al. [42] assessed the composition of the phenolic fraction and the antioxidant capacity (which was estimated using the ORAC method) of oil samples, as well as of the related OMW obtained from two different ripening stages (early and advanced) of the Leccino olive cultivar, in order to compare them and to discover how the phenolic fraction was distributed among the two phases (oil and water) under examination. This work assessed the antioxidant activity of the single phenolic compounds (3,4-DHPEA, p-HPEA and 3,4-DHPEA-EDA) contained in the OMW purified extract (OMW-pe) by using chemical (ORAC) and cellular (CAA-RBC) methods. They found that the antioxidant activity of 3,4-DHPEA is higher than that of the other OPs, whereas the estimated antioxidant activity when considering OMW-pe is similar to that of 3,4-DHPEA-EDA. On the other hand, the CAA-RBC results obtained for OMW-pe and the three phenolic compounds under examination indicated that they are able to permeate through the cell membrane. Moreover, the values obtained from the ORAC analysis were confirmed by the CAA-RBC results and, in particular, it was discovered that 3,4-DHPEA exhibits a greater capacity for cellular antioxidant protection compared to p-HPEA; finally, they recorded a lower value for OMW-pe, similar to that of 3,4-DHPEA-EDA.
Very recently, several simulations of the behavior of EVOO during frying and other cooking processes have been carried out [5,47,48,49]. The most interesting results of these simulations point to the fact that EVOO is extremely stable during deep frying of food (e.g., potatoes), especially at high temperatures [50,51,52] and in the microwave; this seems to indicate that the consumption of OPs contributes to preserving EVOO from oxidative processes, due to its fast reaction with lipid radicals. In fact, the OPs with a higher antioxidant potential (such as 3,4-DHPEA, 3,4-DHPEA-EDA and 3,4-DHPEA-EA) sharply decrease during heating.
In this respect, Gomez-Alonso et al. [53] studied the decrease in the concentration of OPs during several frying repetitions extensively. The results indicated that the amount of OPs was decreased by 40%–50% of the original concentration after 10 min at a temperature of 180 °C (first process). The remaining polyphenolic fraction decreased by less than 10% after six frying operations.
On the other hand, both p-HPEA and the ligstroside derivatives, such as p-HPEA-EDA and p-HPEA-EA, proved highly stable during frying simulation and microwave cooking, providing the confirmation that they are unsuitable for preventing an oxidation reaction in EVOO during cooking processes [54,55]. The stability of tyrosol and its secoiridoid derivatives was further confirmed by other authors: they observed a smaller reduction in their concentration during 12 frying processes than in the hydroxytyrosol family [53].
Moreover, other authors measured the resistance to thermal treatments not only of some secoiridoids derivatives, such as 3,4-DHPEA, elenolic acid, 3,4-DHPEA-EDA and 3,4-DHPEA-EA, but also of lignans. The outcomes of the comparison indicated that lignans are the most thermal resistant compounds in the comparison and that the secoiridoids under examination deteriorated with the thermal treatment faster than other phenols of EVOO, such as 3,4-DHPEA acetate and p-HPEA-EA [55].
Pellegrini et al. [56] found that α-tocopherol (vitamin E) was stabilized by EVOO polyphenols during the heating of olive oil, determining the nutritional value of the cooked foods. This was due to the combined action of phenolic compounds and vitamin E in inhibiting the oxidation processes and in providing a balanced protection under thermal stress.
Over the last decade, many efforts have been spent on identifying the mechanism of the formation of acrylamide whilst frying amylaceous products. In fact, this compound has been classified as carcinogen and must, therefore, be monitored. However, its formation mechanism during cooking at high temperature is not completely clear, but from recent studies, it appears to be related to the Maillard reaction, involving amino acids and reducing sugars. In particular, they believed asparagine, the main amino acid in potatoes, to be its precursor [57,58]. The acrylamide content evaluated in fried potatoes appears to be positively correlated to the colour of the fried food [58].
Napolitano et al. [59] proposed to enrich EVOO with ortho-diphenolic compounds for the purpose of decreasing the acrylamide formation in mild and moderate frying conditions. In fact, these polar antioxidants contribute to inhibiting oxidation in the lipophilic media by acting at the interface between the oil and the polar phase, whereas acrylamide is produced during potato frying. Therefore, it can be affirmed that frying with oil with a high polar compound content is effective in reducing the formation of acrylamide, thanks to the conservation of a chemical reducing environment. Thus, the formation of acrylamide was delayed when dihydroxyphenolic compound enriched EVOO was used.

3. Healthy Aspects of Hydrophilic Phenols of EVOO

As mentioned previously, the efforts spent in recent years studying EVOO phenolic compounds can be ascribed to the fact that these substances show many healthy benefits, including the reduction of the risk factors of coronary heart disease, the prevention of several chronic diseases (for example, atherosclerosis), cancer, chronic inflammation, strokes and other degenerative diseases [60,61,62,63,64,65,66,67,68,69,70], as depicted in Figure 2. In that Figure a schematic representation of the correlation among EVOO health properties and phenolic compounds [7], 3,4DHPEA-EDA in particular [15], was given. In particular, it appears there are different, interconnected mechanisms, as a result of which OPs bear these healthy effects. In fact, OPs work inside cellular compartments as the first line of defense against free radicals, thanks to their antioxidant capacity, such as cellular redox status modulation by enzyme systems. Moreover, the formation and removal of Reactive Oxygen Species (ROS) affects the oxidation processes inside cells (i.e., oxidative stress). In this respect, a large number of acute and chronic, degenerative diseases probably depend on unbalanced levels of ROS, which drive the oxidation process of Low Density Lipoproteins (LDL). In particular, this oxidation process represents one of the first stages of the onset of atherosclerotic lesions [71] and it is also believed to be responsible for DNA modifications, which, as is well known, give rise to the carcinogenic process [72]. In this respect, a reduced activity of the LDL oxidation process, probably due to diets containing olive oils with a high OP content, was observed by several authors, both in vitro and in vivo. Therefore, the efficacy of OPs was made clear not only by considering their capacity as antioxidants, but also by considering hypercholesterolaemic effects. In particular, extensive studies have been carried out on the consumption of EVOO, which guarantees the intake of the OPs supposedly playing a key role in human health. Moreover, an important claim by the EFSA (European Food Safety Authority) was released in 2011 [8], based on several scientific investigations concerning the role of phenols in human health and indeed, the effectiveness of the ingestion of OPs (5 mg/day) on protecting LDL from oxidation.
A very important study recently carried out by Castañer et al. [73] focused on assessing the ability of OPs to modulate the human in vivo expressions of atherosclerosis-related genes, in which the LDL oxidation process plays an important role. The outcomes of the experiment seem to clearly indicate that an intake of phenol enriched EVOO is effective in reducing LDL oxidation, due to the increased antioxidant content of the LDL particle [74,75].
In 2010, two hundred, healthy, non-smoking males from six centers of five European Countries were involved in the EUROLIVE study. They were divided into three groups, each of which was fed 25 mL/day of raw EVOO with a high (366 mg/kg), medium (164 mg/kg) and low (3 mg/kg) phenolic content, respectively, in a randomized, cross-over, double-blind and controlled trial, with a Latin square for three treatments in the cross-over randomized trial. A two-week washout period was used before each EVOO intervention, whereas the intervention period lasted three weeks. They observed a decrease in lipid oxidative damage, in addition to an increase in the cholesterol level of High Density Lipoproteins (HDL), which are strongly dependent on the phenolic content of EVOO. Moreover, the increase in the dependent HDL level of OPs has been observed in other studies on humans [76,77,78,79]. In fact, the increase in HDL cholesterol levels is one of the goals of current, cardiovascular disease therapies [76].
Figure 2. Healthy properties of Ops.
Figure 2. Healthy properties of Ops.
Antioxidants 03 00001 g002
The relationships between the positive effects on health due to OPs and maintaining normal blood HDL cholesterol levels were evaluated by the EFSA. However, there is a need for further experimental findings in order to assess this cause-and-effect relationship [80].
The fact that the functionality of the HDL should be more important than its amount in the blood has been the subject of recent studies. HDL functionality could possibly be related to the promotion of cholesterol efflux from macrophages in the so-called “reverse cholesterol transport” process [81]. It has also been observed that this functionality is affected by HDL oxidation [82,83], which, on the other hand, could be counterbalanced by the antioxidant activity of OPs.
Moreover, feeding 400 mg/kg of EVOO OPs has been proved to improve endothelial function in hypercholesterolemic patients in the postprandial state [84], whereas the daily administration of 340 mg/kg of EVOO OPs for 4 months improved the endothelial function in patients with early atherosclerosis [85].
An improvement of the endothelial function was also observed by Moreno-Luna et al., who carried out a trial on 24 young women with high-normal blood pressure or stage 1 essential hypertension [86]. In that case, they were given 30 mg/day of OP-enriched EVOO as well as OP-free EVOO in a double-blind, randomized, crossover dietary intervention study. They observed a decrease in blood pressure in particular.
The healthy effects of hydroxytyrosol [87] and its glucuronidated metabolites [88] were identified by recent in vitro investigations. These studies pointed out the capacity of both the aforementioned species to inhibit oxidative damage caused by various ROS, as in the case of H2O2, which is recognized as a major cause of endothelial dysfunction [89].
Moreover, platelet aggregation, a key factor in the formation of thrombus and myocardial infarction or angina, has been proved to be affected by OPs. In fact, the activity of the EVOO phenol DHPE (2-(3,4-di-hydroxyphenyl)-ethanol) seems to interfere with 400 mM platelet aggregation in vitro [88]. In this regard, some phenolic compounds appear to have strong, anti-inflammatory effects, both in vitro and in vivo [90,91,92,93,94]. In fact, oleocanthal, which Servili et al. [95] identified for the first time in olives as the dialdehydic form of deacetoxy-ligstroside aglycon (p-HPEA-EDA), shows some features which recall the pharmacological effects of ibuprofen, a modulator of inflammation and analgesia [96]. It was also observed that the activity of both enantiomers of p-HPEA-EDA is responsible for the dose-dependent inhibition of COX-1 and COX-2 (which are cyclo-oxygenase enzymes, catalyzing key-steps in the biochemical inflammation pathways derived from arachidonic acid) activities that can be correlated to the action of ibuprofen. Indeed, the authors suggested the likelihood of a decreased risk in developing certain cancers and lower platelet aggregation in the blood, thanks to a prolonged consumption of oleocanthal, as in the case of its ibuprofen-like, COX-inhibiting activity.
In the last decade, several studies carried out in vitro and in vivo have assessed the antiproliferative and pro-apoptotic effects on cancer cells due to the antioxidant activity of OP, obtained from olive oil and from the by-products of mechanical extraction [97,98,99]. In a recent work, Fabiani et al. [100] stressed the fact that the different phenolic composition of EVOO extracts reflects different chemopreventive activities in vitro towards HL60 cellular lines. The various chemopreventive effects shown by the extracts seem to depend directly on the phenolic composition rather than on their total amount. In fact, the antiproliferative and pro-apoptotic effects are due to 3,4-DHPEA-EDA and p-HPEA-EDA, which are the main components of EVOO extracts. It is important to point out that the concentrations of 3,4-DHPEA-EDA and p-HPEA-EDA in the phenolic extract (with a concentration of 5 µg/mL) used in the culture medium were lower than the pure 3,4-DHPEA-EDA and p-HPEA-EDA concentrations (IC50% 30–35 and 7–8 μM, respectively) needed to obtain a significant effect. Therefore, some synergies between different phenols are likely to be established within the extract.
The negative correlation of 3,4-DHPEA-EDA and p-HPEA-EDA with the antiproliferative and pro-apoptotic effects can be explained in terms of their concentration. In fact, the concentrations of 3,4-DHPEA-EDA and p-HPEA-EDA, when the phenolic extract is dissolved into the culture medium at a concentration of 5 µg/mL, were found to be lower than those needed to achieve an effect on HL60 cells (>10 µM for 3,4-DHPEA and >250 µM for p-HPEA).
As regards lignans, pinoresinol appears to have an insignificant pro-apoptotic activity which, in any case, is sufficient to inhibit the proliferation of HL60 cells, when its concentration is of the order of 10–100 µM, even though its concentration in the phenolic extract was lower. On the other hand, although several studies have demonstrated the chemopreventive properties of 3,4-DHPEA in terms of its antiproliferative and pro-apoptotic effects, the effects of EVOO phenolic extracts on cancer cells are still unclear.
Phenolic compounds have recently been associated with the likelihood of preventing the risk of Alzheimer’s disease and of reducing its related effects, although the mechanism by which the EVOO phenols exert their neuroprotective effects is not completely clear [101]. Alzheimer’s disease is a neurodegenerative disease characterized by an accumulation of amyloid plaques and neurofibrillary tangles in the brain [102]. Recently, several mechanisms have been proposed to describe the role that hydrophilic phenols play in the reduced incidence of Alzheimer’s disease [103,104,105]. Farr et al. [106] found that EVOO OPs (210 mg/kg) have healthy effects on learning and memory deficits of ageing and diseases, such as those related to the overproduction of the amyloid-β peptide. In this study, they demonstrated how OPs were able to reverse oxidative damage in the brains of mice, an age-related learning/memory impairment model associated to an increased amyloid-β protein production and brain oxidative damage. This effect was enhanced by increasing the EVOO OP concentrations (from 210 to 1050 mg/kg).
Abuznait and co-workers [107] carried out experiments in vitro and in vivo on the healthy effects of EVOO hydrophilic phenolic compounds on Alzheimer’s disease. They demonstrated that these effects could be related to the ability of EVOO OPs to reduce the accumulation of amyloid plaques and to enhance β-Amyloid clearance from the blood-brain barrier, thanks to the fact that EVOO OPs improve the action carried out by the two major transport proteins, P-glycoprotein (P-gp) and the LDL lipoprotein receptor-related protein 1 (LRP1) [107].
Finally, as regards the anti-microbial properties of phenolic compounds, it has been observed that the administration of EVOO phenolic compounds also affects the gut microbial balance, due to the fact that they are not completely absorbed into the upper parts of the gastrointestinal tract, whereas they are metabolized in the lower parts by the gut microflora [108]. It is well known that inflammatory signaling pathways are modulated by gut pathogens [109]. Therefore, phenolic compounds could be used to contrast the development of atherosclerosis, thanks to their anti-microbial activity. Moreover, the growth of some beneficial bacteria (such as Lactobacillus) can be selectively enhanced by the OPs [110].

4. Sensorial Aspects of Hydrophilic Phenols of EVOO

The OPs of EVOO strongly affect its sensory properties. The fact that the EVOO phenolic fraction has a strong impact on bitterness, astringency and pungency has been the subject of several past studies [4,5,111,112,113,114]. In this respect, tyrosol, hydroxytyrosol and their relative derivatives are considered responsible for “bitter” EVOO.
In order to establish the correlation between the bitterness of EVOO and the related chemical compounds behind it, Garcia et al. [115] sensorially measured the bitterness of EVOO. By assessing the overall amount of the two secoiridoids derivatives of hydroxytyrosol, the dialdehydic form of decarboxymethyl oleuropein aglycon and the aldehydic form of oleuropein aglycon, they also estimated it chemically. In fact, the sum of the contents of the previously mentioned secoiridoids represents an objective estimation of the oil taste sensation. They found a decrease in the bitterness of EVOO, clearly due to the temperature value adopted during the extraction process. The sensory attributes, including bitterness, were the subject of a quantitative, descriptive analysis. They were estimated, thanks to an analytical panel using a structured, six-point scale, as illustrated in Table 3. A particularly good correlation was discovered between the overall content of the two secoiridoids under examination and the bitterness of EVOO for each olive variety investigated.
Over the last decades, the fact that the attributes of the taste of EVOO had to be ascribed either to the total phenolic content of EVOO or to the lignans fraction, has been the subject of debate. Moreover, a statistical correlation between the total amount of secoiridoids and EVOO sensory responses, such as “astringency” and “bitterness”, has been the subject of a certain number of studies. However, very little data identifying the chemical structures of secoiridoids and their taste attributes has been published.
Table 3. Values of the six points adopted by the panel (Note: with permission from [115], Copyright© American Chemical Society, 2001).
Table 3. Values of the six points adopted by the panel (Note: with permission from [115], Copyright© American Chemical Society, 2001).
Reference valueSensory attributes
0absence of attribute
1simple perception
2light presence
3middle presence
4strong intensity
5highest intensity
In this regard, many authors have hypothesized that the main contributors to the bitterness of EVOO are those compounds with an aromatic ring in their chemical structure, as in the case of the secoiridoid derivatives of oleuropein (3,4-DHPEA-EDA and 3,4-DHPEA-EA) [116,117]. Furthermore, Tovar et al. [117] confirmed this hypothesis by proving that p-HPEA-EDA is responsible for the bitter and pungent sensory notes of EVOO.
Moreover, Gutiérrez-Rosales et al. [118] isolated every secoiridoid derivative for the first time in 2003, by using the preparative HPLC technique to assess the intensity of its bitterness. The authors associated the relevant peaks with 3,4-DHPEA-EDA, 3,4-DHPEA-EA and p-HPEA-EDA, which were mainly responsible for the bitterness of EVOO. In particular, they observed a strong correlation between the content of 3,4-DHPEA-EDA (r = 0.9819 p ≤ 10−3), p-HPEA-EDA (r = 0.9830 p ≤ 10−3) and 3,4-DHPEA-EA (r = 0.7929 p ≤ 10−2) and the intensity of the bitterness.
A recent work by Andrewes et al. [119] correlated the chemical structures of secoiridoids, such as p-HPEA-EDA and 3,4-DHPEA-EDA, with the burning/pungent sensory notes of EVOO. These secoiridoids were isolated in EVOO in two different fractions; one containing p-HPEA-EDA featured a strong burning/pungent sensation, whereas the fraction containing 3,4-DHPEA-EDA had a slight burning/pungent sensation, which was perceived more on the tongue. This confirmed the fact that the burning-pungent sensory note in EVOO is mainly caused by p-HPEA-EDA. On the other hand, they did not identify any other polyphenolic fractions producing such an intense sensation.
In 2005, Beauchamp et al. [96] confirmed the outcomes of the aforementioned study. In fact, they used a synthesized p-HPEA-EDA (renamed oleocanthal), dissolved into non-irritating corn oil, and tested the throat-irritant properties of this compound. They found a dose-dependent effect similar to that of the same compound found in EVOO, probably due to the two dialdehydic groups found in the chemical structure.
Recent investigations on p-HPEA-EDA have been carried out in order to characterize the spatial location of irritation it produces. Peyrot des Gachons et al. [120] reported that all the regions in the oral cavity are aggravated by irritating, pungent substances, which do not act on one localized area. This implies that a sensory receptor specific to p-HPEA-EDA exists in the oropharyngeal region of the oral cavity. More recent studies by Hayes et al. [121] identified TRPA1 as the p-HPEA-EDA receptor located, from an anatomical point of view, in the oropharyngeal region of the oral cavity [120,122].

5. Conclusions

The EVOO quality is intimately affected by its content in phenolic compounds. In fact, the hydrophilic phenols influence not only its shelf-life but also its health and sensory proprieties.
The review has been focused on the evaluation of the antioxidant effects of OPs. In particular, the antioxidant activities and healthy properties of secoiridoids derivatives, such as 3,4-DHPEA, 3,4-DHPEA-EDA, 3,4-DHPEA-EA, p-HPEA, p-HPEAEDA and lignans, have been taken into account. It was found that the high resistance to oxidation of EVOO is due to oleuropein and 3,4-DHPEA-EA derivatives, while lignans play a secondary role. Moreover, with respect to the healthy properties, these substances show a high antioxidant activity and play a key role in the prevention and/or reduction of chronic degenerative events based on inflammatory processes and chronic-degenerative diseases, such as cardiovascular-cerebral diseases and cancer. Furthermore, it was also found that the sensory notes of EVOO are affected by OPs. In fact, it was demonstrated that open ring p-HPEA-EDA is responsible for the strong “pungent” attribute, while closed ring 3,4-DHPEA-EA and p-HPEA-EA represent the impact components for the “bitter” note. The 3,4-DHPEA-EDA, which contributes to the sensation of bitter however, plays a marginal role for the “pungent” note.
In recent years, the innovation process in the field of EVOO is being orienting towards a new concept of quality, strictly related to OPs content (which, more than other compounds, are affected by technological processes) to end of producing EVOOs characterized by a strong sensory impact and healthy benefits.


The authors wish to acknowledge the Consorzio Olivicolo Italiano UNAPROL—Italy (projects Reg. EC n. 2080/2005 and n. 867/2008) for the financial support.

Conflicts of Interest

The authors declare no conflict of interest.


  1. Knoops, K.T.B.; de Groot, L.C.; Kromhout, D.; Perrin, A.E.; Moreiras-Varela, O.; Menotti, A.; van Staveren, W.A. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: The HALE project. JAMA 2004, 292, 1433–1439. [Google Scholar] [CrossRef]
  2. Bach-Faig, A.; Berry, E.M.; Lairon, D.; Reguant, J.; Trichopoulou, A.; Dernini, S.; Medina, F.X.; Battino, M.; Belahsen, R.; Miranda, G.; et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011, 14, 2274–2284. [Google Scholar] [CrossRef]
  3. European Union. Commision Regulation (EU) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health. Off. J. Eur. Union 2012, L136, 1–40. [Google Scholar]
  4. Servili, M.; Selvaggini, R.; Esposto, S.; Taticchi, A.; Montedoro, G.F.; Morozzi, G. Health and sensory properties of virgin olive oil hydrophilic phenols: Agronomic and technological aspect of production that affect their occurrence in the oil. J. Chromatgr. 2004, 1054, 113–127. [Google Scholar] [CrossRef]
  5. Servili, M.; Esposto, S.; Fabiani, R.; Urbani, S.; Taticchi, A.; Mariucci, F.; Selvaggini, R.; Montedoro, G.F. Phenolic compounds in olive oil: Antioxidant, health and organoleptic activities according to their chemical structure. Inflammopharmacology 2009, 17, 1–9. [Google Scholar] [CrossRef]
  6. Omar, S.H. Oleuropein in olive and its pharmacological effects. Sci. Pharm. 2010, 78, 133–154. [Google Scholar] [CrossRef]
  7. Obied, H.K.; Prenzler, P.D.; Omar, S.H.; Ismael, R.; Servili, M.; Esposto, S.; Taticchi, A.; Selvaggini, R.; Urbani, S. Pharmacology of Olive Biophenols. In Advances in Molecular Toxicology; Fishbein, J.C., Heilman, J.M., Eds.; Elsevier: Amsterdam, The Netherlands, 2012; Volume 6, pp. 195–223. [Google Scholar]
  8. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 2011, 9, 1–25. [Google Scholar] [CrossRef]
  9. Boskou, D. Olive Oil Composition. In Olive Oil Chemistry and Technology; Boskou, D., Ed.; AOC Press: Champaign, IL, USA, 1996; pp. 52–83. [Google Scholar]
  10. Inglese, P.; Famiani, F.; Galvano, F.; Servili, M.; Esposto, S.; Urbani, S. Factors Affecting Extra-Virgin Olive Oil Composition. In Horticultural Reviews; Janik, J., Ed.; John Wiley & Sons Pubs.: Hoboken, NJ, USA, 2011; Volume 38, pp. 83–148. [Google Scholar]
  11. El Riachy, M.; Priego-Capote, F.; León, L.; Rallo, L.; Luque de Castro, M.D. Hydrophilic antioxidants of virgin olive oil. Part 2: Biosynthesis and biotransformation of phenolic compounds in virgin olive oil as affected by agronomic and processing factors. Eur. J. Lipid Sci. Technol. 2011, 113, 692–707. [Google Scholar] [CrossRef]
  12. Shahidi, F. Chemistry, Health Effect and Applications. In Natural Antioxidants; Shahidi, F., Ed.; The American Oil Chemists Society: Champaign, IL, USA, 1996; pp. 97–149. [Google Scholar]
  13. Vasquez Roncero, A. Les polyphenols de l’huile d’olive et leur influence sur les characteristiques de l’huile. Rev. Française Corps Gras 1978, 25, 21–26. [Google Scholar]
  14. Rovellini, P.; Cortesi, N.; Fedeli, E. Analysis of flavonoids from Olea europaea by HPLC-UV and HPLC-electrospray-MS. Riv. Ital. Sostanze Grasse 1997, 74, 273–279. [Google Scholar]
  15. Servili, M.; Montedoro, G.F. Contribution of phenolic compounds to virgin olive oil quality. Eur. J. Lipid Sci. Technol. 2002, 104, 602–613. [Google Scholar] [CrossRef]
  16. Montedoro, G.F.; Servili, M.; Baldioli, M.; Miniati, E. Simple and hydrolyzable phenolic compounds in virgin olive oil. 2. Initial characterization of the hydrolyzable fraction. J. Agric. Food Chem. 1992, 40, 1577–1580. [Google Scholar] [CrossRef]
  17. Tsimidou, M.; Lytridou, M.; Boskou, D.; Pappa-Louisi, A.; Kotsifaki, F.; Petrakis, C. On the determination of minor phenolic acids of virgin olive oil by RP-HPLC. Grasas Aceites 1996, 47, 151–157. [Google Scholar] [CrossRef]
  18. Brenes, M.; García, A.; García, P.; Garrido, A. Acid hydrolysis of. secoiridoid aglycons during storage of virgin olive oil. J. Agric. Food Chem. 2001, 49, 5609–5614. [Google Scholar] [CrossRef]
  19. Owen, R.W.; Mier, W.; Giacosa, A.; Hull, W.E.; Spiegelhalder, B.; Bartsch, H. Olive-oil consumption and health: The possible role of antioxidants. Food Chem. Toxicol. 2000, 38, 647–659. [Google Scholar] [CrossRef]
  20. Brenes, M.; Hidalgo, F.J.; García, A.; Rios, J.J.; García, P.; Zamora, R.; Garrido, A. Pinoresinol and 1-acetoxypinoresinol, two new phenolic compounds identified in olive oil. J. Am. Oil Chem. Soc. 2000, 77, 715–720. [Google Scholar] [CrossRef]
  21. Montedoro, G.F.; Servili, M.; Baldioli, M.; Miniati, E. Simple and hydrolyzable compounds in virgin olive oil. 1. Their ex-traction, separation and quantitative and semiquantitative evaluation by HPLC. J. Agric. Food Chem. 1992, 40, 1571–1576. [Google Scholar] [CrossRef]
  22. Montedoro, G.F.; Servili, M.; Baldioli, M.; Selvaggini, R.; Miniati, E.; Macchioni, A. Simple and hydrolyzable phenolic compounds in virgin olive oil. 3. Spectroscopic characterizations of the secoiridoid derivatives. J. Agric. Food Chem. 1993, 41, 2228–2234. [Google Scholar] [CrossRef]
  23. Angerosa, F.; d’Alessandro, N.; Corana, F.; Mellerio, G. Characterization of phenolic and secoiridoid aglycons present in virgin olive oil by gas chromatography-chemical ionization mass spectrometry. J. Chromatogr. 1996, 736, 195–203. [Google Scholar] [CrossRef]
  24. Montedoro, G.F.; Servili, M.; Baldioli, M. The Use of biotechnology means during oil mechanical extraction process: Relationship with sensory and nutritional parameters of virgin olive oil quality. Acta Hortic. 2002, 586, 557–560. [Google Scholar]
  25. Garrido Fernández, A.; Fernández Díez, M.J.; Adamos, M.R. Physical and Chemical Characteristics of the Olive Fruit. In Table Olives; Garrido Fernández, A., Fernández Díez, M.J., Adams, M.R., Eds.; Chapman & Hall: London, UK, 1997; pp. 67–109. [Google Scholar]
  26. Gucci, R.; Caruso, G.; Bertolla, C.; Urbani, S.; Taticchi, A.; Esposto, S.; Servili, M.; Sifola, M.I.; Pellegrini, S.; Pagliai, M.; et al. Changes of soil properties and tree performance induced by soil management in a high-density olive orchard. Eur. J. Agron. 2012, 41, 18–27. [Google Scholar] [CrossRef]
  27. Tovar, M.J.; Romero, M.P.; Girona, J.; Motilva, M.J. l-Phenylalanine ammonia-lyase activity and concentration of phenolics in developing olive (Olea europaea L. cv Arbequina) fruit grown under different irrigation regimes. J. Sci. Food Agric. 2002, 82, 892–898. [Google Scholar] [CrossRef]
  28. Servili, M.; Esposto, S.; Lodolini, E.; Selvaggini, R.; Taticchi, A.; Urbani, S.; Montedoro, G.F.; Serravalle, M.; Gucci, R. Irrigation effects on quality, phenolic composition, and selected volatiles of virgin olive oils cv. leccino. J. Agric. Food Chem. 2007, 55, 6609–6618. [Google Scholar] [CrossRef]
  29. Tura, D.; Failla, O.; Pedò, S.; Gigliotti, C.; Bassi, D.; Serraiocco, A. Effects of seasonal weather variability on olive oil composition in Northern Italy. Acta Hortic. 2008, 791, 769–776. [Google Scholar]
  30. Bellincontro, A.; Taticchi, A.; Servili, M.; Esposto, S.; Farinelli, D.; Mencarelli, F. Feasible application of a portable NIR-AOTF tool for on-field prediction of phenolic compounds during the ripening of olives for oil production. Agric. Food Chem. 2012, 60, 2665–2673. [Google Scholar] [CrossRef]
  31. Tombesi, A.; Farinelli, D.; Ruffolo, M. Programmazione della raccolta per un olio di oliva di qualità. Riv. Frutticolt. Ortofloric. 2009, 10, 21–26. [Google Scholar]
  32. Di Giovacchino, L.; Solinas, M.; Miccoli, M. Effect of extraction systems on the quality of virgin olive oil. J. Am. Oil Chem. Soc. 1994, 71, 1189–1194. [Google Scholar] [CrossRef]
  33. Caponio, F.; Alloggio, V.; Gomes, T. Phenolic compounds of virgin olive oil: Influence of paste preparation techniques. Food Chem. 1999, 64, 203–209. [Google Scholar] [CrossRef]
  34. Servili, M.; Taticchi, A.; Esposto, S.; Urbani, S.; Selvaggini, R.; Montedoro, G.F. Influence of the decrease in oxygen during malaxation of olive paste on the composition of volatiles and phenolic compounds in virgin olive oil. J. Agric. Food Chem. 2008, 59, 10048–10055. [Google Scholar]
  35. Servili, M.; Taticchi, A.; Esposto, S.; Urbani, S.; Selvaggini, R.; Montedoro, G.F. Innovations in the Extraction Technology for the Improvement of the Virgin Olive Oil Quality. In Proceedings of 6th Euro Fed Lipid Congress, Athens, Greece, 7–10 September 2008; p. 138.
  36. Servili, M.; Taticchi, A.; Esposto, S.; Sordini, B.; Urbani, S. Technological Aspects of Olive Oil Production. In Olive Germplasm—The Olive Cultivation, Table Olive and Olive Oil Industry in Italy; Muzzalupo, I., Ed.; Intech: Rijeka, Croatia, 2012. [Google Scholar]
  37. Taticchi, A.; Esposto, S.; Veneziani, G.; Urbani, S.; Selvaggini, R.; Servili, M. The influence of the malaxation temperature on the activity of polyphenoloxidase and peroxidase and on the phenolic composition of virgin olive oil. Food Chem. 2013, 136, 975–983. [Google Scholar] [CrossRef]
  38. Vierhuis, E.; Servili, M.; Baldioli, M.; Schols, H.A.; Voragen, A.G.J.; Montedoro, G.F. Effect of enzyme treatment during mechanical extraction of olive oil on phenolic compounds and polysaccharides. J. Agric. Food Chem. 2001, 49, 1218–1223. [Google Scholar] [CrossRef]
  39. Baldioli, M.; Servili, M.; Perretti, G.; Montedoro, G.F. Antioxidant activity of tocopherols and phenolic compounds of virgin olive oil. J. Am. Oil Chem. Soc. 1996, 73, 1589–1593. [Google Scholar] [CrossRef]
  40. Pirisi, F.M.; Cabras, P.; Cao, C.F.; Migliorini, M.; Muggelli, M. Phenolic compounds in virgin olive oil. 2. Reappraisal of the extraction, HPLC separation, and quantification procedures. J. Agric. Food Chem. 2000, 48, 1191–1196. [Google Scholar] [CrossRef]
  41. Ninfali, P.; Aluigi, G.; Bacchiocca, M.; Magnani, M. Antioxidant capacity of vegetable oils. J. Am. Oil Chem. Soc. 2001, 78, 243–247. [Google Scholar] [CrossRef]
  42. Angelino, D.; Gennari, L.; Blasa, M.; Selvaggini, R.; Urbani, S.; Esposto, S.; Servili, M.; Ninfali, P. Chemical and cellular antioxidant activity of phytochemicals purified from olive mill waste waters. J. Agric. Food Chem. 2011, 59, 2011–2018. [Google Scholar] [CrossRef]
  43. Artajo, L.S.; Romero, M.P.; Morello, J.R.; Motilva, M.J. Enrichment of refined olive oil with phenolic compounds: Evaluation of their antioxidant activity and their effect on the bitter index. J. Agric. Food Chem. 2006, 54, 6079–6088. [Google Scholar] [CrossRef]
  44. Carrasco-Pancorbo, A.; Cerretani, L.; Bendini, A.; Segura-Carretero, A.; del Carlo, M.; Gallina-Toschi, T.; Lercker, G.; Compagnone, D.; Fernández-Gutiérrez, A. Evaluation of the antioxidant capacity of individual phenolic compounds in virgin olive oil. J. Agric. Food Chem. 2005, 53, 8918–8925. [Google Scholar] [CrossRef]
  45. Obied, H.K.; Karuso, P.; Prenzler, P.D.; Robards, K. Novel secoiridoids with antioxidant activity from Australian olive mill waste. J. Agric. Food Chem. 2007, 55, 2848–2853. [Google Scholar] [CrossRef]
  46. Obied, H.K.; Prenzler, P.D.; Robards, K. Potent antioxidant biophenols from olive mill waste. Food Chem. 2008, 111, 171–178. [Google Scholar] [CrossRef]
  47. Procida, G.; Cichelli, A.; Compagnone, D.; Maggio, R.M.; Cerretani, L.; del Carlo, M. Influence of chemical composition of olive oil on the development of volatile compounds during frying. Eur. Food Res. Technol. 2009, 230, 217–229. [Google Scholar] [CrossRef]
  48. Santos, C.S.P.; Cruz, R.; Cunha, S.C.; Casal, S. Effect of cooking on olive oil quality attributes. Food Res. Int. 2013, 54, 2016–2024. [Google Scholar] [CrossRef]
  49. Chiou, A.; Kalogeropoulos, N.; Boskou, G.; Salta, F.N. Migration of health promoting microconstituents from frying vegetable oils to French fries. Food Chem. 2012, 133, 1255–1263. [Google Scholar] [CrossRef]
  50. Andrikopoulos, N.K.; Tzamtzis, V.A.; Giannopoulos, G.A. Deterioration of some vegetable oils: I. During heating or frying of several foods. Rev. Française Corps Gras 1989, 3–4, 127–129. [Google Scholar]
  51. Tuǧba, İ.; Maskan, M. The potential application of plant essential oils/extracts as natural preservatives in oils during processing: A review. J. Food Sci. Eng. 2012, 2, 1–9. [Google Scholar]
  52. Silva, L.; Pinto, C.J.; Paiva-Martins, F. Oxidative stability of olive oil after food processing and comparison with other vegetable oils. Food Chem. 2010, 121, 1177–1187. [Google Scholar] [CrossRef]
  53. Gomez-Alonso, S.; Fregapane, G.; Salvador, M.; Gordon, M.H. Changes in phenolic composition and antioxidant activity of virgin olive oil during frying. J. Agric. Food Chem. 2003, 51, 667–672. [Google Scholar] [CrossRef]
  54. Daskalaki, D.; Kefi, G.; Kotsiou, K.; Tasioula-Margari, M. Evaluation of phenolic compounds degradation in virgin olive oil during storage and heating. J. Food Nutr. Res. 2009, 48, 31–41. [Google Scholar]
  55. Carrasco-Pancorbo, A.; Cerretani, L.; Bendini, A.; Segura-Carretero, A.; Lercker, G.; Fernandez-Gutierrez, A. Evaluation of the influence of thermal oxidation on the phenolic composition and on the antioxidant activity of extra-virgin olive oils. J. Agric. Food Chem. 2007, 55, 4771–4780. [Google Scholar] [CrossRef]
  56. Pellegrini, N.; Visioli, F.; Buratti, S.; Brighenti, F. Direct analysis of total antioxidant activity of olive oil and studies on the influence of heating. J. Agric. Food Chem. 2001, 49, 2532–2538. [Google Scholar] [CrossRef]
  57. Tareke, E.; Rydberg, P.; Karlsson, P.; Eriksson, S.; Tőrnqvist, M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J. Agric. Food Chem. 2002, 50, 4998–5006. [Google Scholar] [CrossRef]
  58. Pedreschi, F.; Moyano, P.; Kaack, K.; Granby, K. Colour changes and acrylamide formation in fried potato slices. Food Res. Int. 2005, 38, 1–9. [Google Scholar] [CrossRef]
  59. Napolitano, A.; Morales, F.; Sacchi, R.; Fogliano, V. Relationship between virgin olive oil phenolic compounds and acrylamide formation in fried crisps. J. Agric. Food Chem. 2008, 56, 2034–2040. [Google Scholar] [CrossRef] [PubMed]
  60. Cicerale, S.; Lucas, L.J.; Keast, R.S.J. Antimicrobial, antioxidant and anti-inflammatory phenolic activities in Extra Virgin OLive Oil. Curr. Opin. Biotechnol. 2012, 23, 129–135. [Google Scholar] [CrossRef]
  61. Frankel, E.N. Nutritional and biological properties of Extra Virgin Olive Oil. J. Agric. Food Chem. 2011, 59, 785–792. [Google Scholar] [CrossRef]
  62. López-Miranda, J.; Pérez-Jiménez, F.; Ros, E.; de Caterina, R.; Badimón, L.; Covas, M.I.; Escrich, E.; Ordovás, J.M.; Soriguer, F.; Abiá, R.; et al. Olive oil and health: Summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 284–294. [Google Scholar] [CrossRef]
  63. Covas, M.I. Olive oil and the cardiovascular system. Pharmacol. Res. 2007, 55, 175–186. [Google Scholar] [CrossRef]
  64. Fortes, C.; García-Vilas, J.A.; Quesada, A.R.; Medina, M.A. Evaluation of the anti-angiogenic potential of hydroxytyrosol and tyrosol, two bio-active phenolic compounds of extra virgin olive oil, in endothelial cell cultures. Food Chem. 2012, 134, 134–140. [Google Scholar] [CrossRef]
  65. Visioli, F. Olive oil phenolics: Where do we stand? Where should we go? J. Sci. Food Agric. 2012, 92, 2017–2019. [Google Scholar] [CrossRef]
  66. Oliveras-López, M.J.; Muros Molina, J.J.; Villalón Mir, M.; Fontao Rey, I.; Martín, F.; López-Garcia de la, S. Extra virgin olive oil (EVOO) consumption and antioxidant status in healthy institutionalized elderly humans. Arch. Gerontol. Geriatr. 2013, 57, 234–242. [Google Scholar] [CrossRef]
  67. Casaburi, I.; Puoci, F.; Chimento, A.; Sirianni, R.; Ruggiero, C.; Avena, P.; Pezzi, V. Potential of olive oil phenols as chemopreventive and therapeutic agents against cancer: A review of in vitro studies. Mol. Nutr. Food Res. 2013, 57, 71–83. [Google Scholar] [CrossRef]
  68. Fabiani, R.; Sepporta, M.V.; Rosignoli, P.; De Bartolomeo, A.; Crescimanno, M.; Morozzi, G. Anti-proliferative and pro-apoptotic activities of hydroxytyrosol on different tumour cells: The role of extracellular production of hydrogen peroxide. Eur. J. Nutr. 2011, 51, 455–464. [Google Scholar] [PubMed]
  69. Fabiani, R.; de Bartolomeo, A.; Rosignoli, P.; Servili, M.; Selvaggini, R.; Montedoro, G.F.; di Saverio, C.; Morozzi, G. Virgin olive oil phenols inhibit proliferation of human promyelocytic leukemia cells (HL60) by inducing apoptosis and differentiation. J. Nutr. 2006, 136, 614–619. [Google Scholar] [PubMed]
  70. Carrera-González, M.P.; Ramírez-Exposito, M.J.; Mayas, M.D.; Martínez-Martos, J.M. Protective role of oleuropein and its metabolite hydroxytyrosol on cancer. Trends Food Sci. Technol. 2013, 31, 92–99. [Google Scholar] [CrossRef]
  71. Berliner, J.A.; Navab, M.; Fogelman, A.M.; Frank, J.S.; Demer, L.L.; Edwards, P.A.; Watson, A.D.; Lusis, A.J. Atherosclerosis: Basic mechanisms: Oxidation, inflammation and genetics. Circulation 1995, 91, 2488–2496. [Google Scholar] [CrossRef]
  72. Nakae, D.; Kobayashi, Y.; Akai, H.; Andoh, N.; Satoh, H.; Ohashi, K.; Tsutsumi, M.; Konishi, Y. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res. 1997, 57, 1281–1287. [Google Scholar] [PubMed]
  73. Castañer, O.; Covas, M.I.; Khymenets, O.; Nyyssonen, K.; Konstantinidou, V.; Zunft, H.-F.; de la Torre, R.; Muñoz-Aguayo, D.; Vila, J.; Fitó, M. Protection of LDL from oxidation by olive oil polyphenols is associated with a downregulation of CD40-ligand expression and its downstream products in vivo in humans1–3. Am.J. Clin. Nutr. 2012, 95, 1238–1244. [Google Scholar] [CrossRef]
  74. Gimeno, E.; Fitó, M.; Lamuela-Raventó, R.M.; Castellote, A.I.; Covas, M.I.; Farré, M.; de la Torre-Boronat, M.C.; López-Sabater, M.C. Effect of ingestion of virgin olive oil on human low-density lipoprotein composition. Eur. J. Clin. Nutr. 2002, 56, 114–120. [Google Scholar] [CrossRef]
  75. Castañer, O.; Fitó, M.; López-Sabater, M.C.; Poulsen, H.E.; Nyyssönen, K.; Schröder, H.; Salonen, J.T.; de la Torre-Carbot, K.; Zunft, H.F.; de la Torre, R.; et al. The effect of olive oil polyphenols on antibodies against oxidized LDL. A randomized clinical trial. Clin. Nutr. 2011, 30, 490–493. [Google Scholar] [CrossRef]
  76. Martín-Peláez1, S.; Covas, M.I.; Fitó, M.; Kušar, A.; Pravst, I. Health effects of olive oil polyphenols: Recent advances and possibilities for the use of health claims. Mol. Nutr. Food Res. 2013, 57, 760–771. [Google Scholar] [CrossRef]
  77. Covas, M.I.; Nyyssönen, K.; Poulsen, H.E.; Kaikkonen, J.; Zunft, H.F.; Kiesewetter, H.; Gaddi, A.; de la Torre, R.; Mursu, J.; Bäumler, H.; et al. The effect of polyphenols in olive oil on heart disease risk factors—A randomized trial. Ann. Intern. Med. 2006, 145, 333–341. [Google Scholar] [CrossRef]
  78. Helal, O.; Berrougui, H.; Loued, S.; Khalil, A. Extra-virgin olive oil consumption improves the capacity of HDL to mediate cholesterol efflux and increases ABCA1 and ABCG1 expression in human macrophages. Br. J. Nutr. 2013, 109, 1844–1855. [Google Scholar] [CrossRef]
  79. Grundy, S.M.; Cleeman, J.I.; Bairey Merz, C.N.; Brewer, H.B.; Clark, L.T., Jr.; Hunninghake, D.B.; Pasternak, R.C.; Smith, S.C.; Stone, N.J., Jr. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines free. J. Am. Coll. Cardiol. 2004, 44, 720–732. [Google Scholar] [CrossRef]
  80. EFSA. NDA Panel, Scientific Opinion on the substantiation of a health claim related to polyphenols in olive and maintenance of normal blood HDL cholesterol concentrations (ID 1639, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 2012, 10. [CrossRef]
  81. Rosenson, R.S.; Brewer, H.B., Jr.; Davidson, W.S.; Fayad, Z.A.; Fuster, V.; Goldstein, J.; Hellerstein, M.; Jiang, X.C.; Phillips, M.C.; Rader, D.J.; et al. Cholesterol efflux and atheroprotection advancing the concept of reverse cholesterol transport. Circulation 2012, 125, 1905–1919. [Google Scholar] [CrossRef]
  82. Shao, B. Site-specific oxidation of apolipoprotein A–I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. Biochim. Biophys. ActaProteins Proteomics 2012, 1821, 490–501. [Google Scholar] [CrossRef]
  83. Farràs, M.; Valls, R.M.; Fernández-Castillejo, S.; Giralt, M.; Solà, R.; Subirana, I.; Motilva, M.J.; Konstantinidou, V.; Covas, M.I.; Fitó, M. Olive oil polyphenols enhance the expression of cholesterol efflux related genes in vivo in humans. A randomized controlled trial. J. Nutr. Biochem. 2013, 24, 1334–1339. [Google Scholar] [CrossRef]
  84. Ruano, J.; López-Miranda, J.; Fuentes, F.; Moreno, J.A.; Bellido, C.; Perez-Martinez, P.; Lozano, A.; Gómez, P.; Jiménez, Y.; Pérez Jiménez, F. Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J. Am. Coll. Cardiol. 2005, 46, 1864–1868. [Google Scholar] [CrossRef]
  85. Jiménez-Morales, A.I.; Ruano, J.; Delgado-Lista, J.; Fernandez, J.M.; Camargo, A.; López-Segura, F.; Caballero Villarraso, J.; Fuentes-Jiménez, F.; López-Miranda, J.; Pérez-Jiménez, F. NOS3 Glu298Asp polymorphism interacts with virgin olive oil phenols to determine the postprandial endothelial function in patients with the metabolic syndrome. J. Clin. Endocrinol. Metab. 2011, 96, E1694–E1702. [Google Scholar] [CrossRef]
  86. Moreno-Luna, R.; Muñoz-Hernandez, R.; Miranda, M.L.; Costa, A.F.; Jimenez-Jimenez, L.; Vallejo-Vaz1, A.J.; Muriana, F.J.G.; Villar, J.; Stiefel, P. Olive oil polyphenols decrease blood pressure and improve endothelial function in young women with mild hypertension. Am. J. Hypertens. 2012, 25, 1299–1304. [Google Scholar] [PubMed]
  87. Zrelli, H.; Matsuoka, M.; Kitazaki, S.; Zarrouk, M.; Miyazaki, H. Hydroxytyrosol reduces intracellular reactive oxygen species levels in vascular endothelial cells by upregulating catalase expression through the AMPK-FOXO3a pathway. Eur. J. Pharmacol. 2011, 660, 275–282. [Google Scholar] [CrossRef]
  88. Deiana, M.; Incani, A.; Rosa, A.; Atzeri, A.; Loru, D.; Cabboi, B.M.; Melis, P.; Lucas, R.; Morales, J.C.; Dessì, M.A. Hydroxytyrosol glucuronides protect renal tubular epithelial cells against H(2)O(2) induced oxidative damage. Chem. Biol. Interact. 2011, 193, 232–239. [Google Scholar] [CrossRef]
  89. Victor, V.M.; Rocha, M.; Sola, E.; Banuls, C.; Garcia-Malpartida, K.; Hernandez-Mijares, A. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr. Pharm. Des. 2009, 15, 2988–3002. [Google Scholar] [CrossRef]
  90. Petroni, A.; Blasevich, M.; Salami, M.; Papini, N.; Montedoro, G.F.; Galli, C. Inhibition of platelet-aggregation and eicosanoid production by phenolic components of olive oil. Thromb. Res. 1995, 78, 151–160. [Google Scholar] [CrossRef]
  91. McGeer, P.L.; McGeer, E.G.; Schwab, C. Inflammatory processes exacerbate degenerative neurological disorders. Curr. Hypotheses Res. Milest. Alzheimer’s Dis. 2009, 117–124. [Google Scholar] [CrossRef]
  92. Scoditti, E.; Calabriso, N.; Massaro, M.; Pellegrino, M.; Storelli, C.; Martines, G.; de Caterina, R.; Carluccio, M.A. Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch. Biochem. Biophys. 2012, 527, 81–89. [Google Scholar] [CrossRef]
  93. Cicerale, S.; Lucas, L.; Keast, R. Biological activities of phenolic compounds present in virgin olive oil. Int. J. Mol. Sci. 2010, 11, 458–479. [Google Scholar] [CrossRef]
  94. Rosignoli, P.; Fuccelli, R.; Fabiani, R.; Servili, M.; Morozzi, G. Effect of olive oil phenols on the production of inflammatory mediators in freshly isolated human monocytes. J. Nutr. Biochem. 2013, 24, 1513–1519. [Google Scholar] [CrossRef]
  95. Servili, M.; Baldioli, M.; Selvaggini, R.; Miniati, E.; Macchioni, A.; Montedoro, G.F. High-Performance Liquid Chromatography evaluation of phenols in olive fruit, virgin olive oil, vegetation waters and pomace and 1D- and 2D-Nuclear Magnetic Resonance characterization. J. Am. Oil Chem. Soc. 1999, 76, 873–882. [Google Scholar] [CrossRef]
  96. Beauchamp, G.K.; Keast, R.S.J.; Morel, D.; Lin, J.; Pika, J.; Han, Q.; Lee, C.H.; Smith, A.B.; Breslin, P.A.S. Ibuprofen-like activity in extra-virgin olive oil. Nature 2005, 437, 45–46. [Google Scholar] [CrossRef]
  97. Gill, C.I.R.; Boyd, A.; McDermott, E.; McCann, M.; Servili, M.; Selvaggini, R.; Taticchi, A.; Esposto, S.; Montedoro, G.F.; McGlynn, H.; et al. Potential anti-cancer effects of virgin olive oil phenolson colorectal carcinogenesis models in vitro. Int. J. Cancer 2005, 117, 1–7. [Google Scholar] [CrossRef]
  98. Hashim, Y.Z.; Rowland, I.R.; McGlynn, H.I.; Servili, M.; Selvaggini, R.; Taticchi, A.; Esposto, S.; Montedoro, G.; Kaisalo, L.; Wähälä, K.; et al. Inhibitory effects of olive oil phenolics on invasion in human colon adenocarcinoma cells in vitro. Int. J. Cancer 2008, 122, 495–500. [Google Scholar] [CrossRef] [PubMed]
  99. Femia, A.P.; Dolara, P.; Servili, M.; Esposto, S.; Taticchi, A.; Urbani, S.; Giannini, P.; Salvadori, M.; Caderni, G. No effects of olive oils with different phenolic content compared to corn oil on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Eur. J. Nutr. 2008, 47, 329–334. [Google Scholar] [CrossRef]
  100. Fabiani, R.; Rosignoli, P.; de Bartolomeo, A.; Fuccelli, R.; Servili, M.; Morozzi, G. The production of hydrogen peroxide is not a common mechanism by which olive oil phenols induce apoptosis on HL60 cells. Food Chem. 2011, 125, 1249–1255. [Google Scholar] [CrossRef]
  101. Dell’Agli, M.; Fagnani, R.; Mitro, N.; Scurati, S.; Masciadri, M.; Mussoni, L.; Galli, G.V.; Bosisio, E.; Crestani, M.; de Fabiani, E.; et al. Minor components of olive oil modulate proatherogenic adhesion molecules involved in Endothelial activation. J. Agric. Food Chem. 2006, 54, 3259–3264. [Google Scholar] [CrossRef] [PubMed]
  102. Zlokovic, B.V.; Frangione, B. Transport-Clearancehypothesis for Alzheimer’s Disease and Potential Therapeuticimplications. In Aβ Metabolism in Alzheimer’s Disease; Saido, T.C., Ed.; Landes Bioscience: Georgetown, TX, USA, 2003; pp. 114–122. [Google Scholar]
  103. Li, W.; Sperry, J.B.; Crowe, A.; Trojanowski, J.Q.; Smith, A.B.; Lee, V.M. Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau. J. Neurochem. 2009, 110, 1339–1351. [Google Scholar] [CrossRef]
  104. Monti, M.C.; Margarucci, L.; Tosco, A.; Riccio, R.; Casapullo, A. New insights on the interaction mechanism between tau protein and oleocanthal, an extra-virgin olive-oil bioactive component. Food Funct. 2011, 2, 423–428. [Google Scholar] [CrossRef] [PubMed]
  105. Pitt, J.; Roth, W.; Lacor, P.; Smith, A.B.; Blankenship, M.; Velasco, P.; de Felice, F.; Breslin, P.; Klein, W.L. Alzheimer’s-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol. Appl. Pharmacol. 2009, 240, 189–197. [Google Scholar] [CrossRef]
  106. Farr, S.A.; Price, T.O.; Dominguez, L.J.; Motisi, A.; Saiano, F.; Niehoff, M.L.; Morley, J.E.; Banks, W.A.; Ercal, N.; Barbagallo, M. Extra virgin olive oil improves learning and memory in SAMP8 mice. J. Alzheimer’s Dis. 2012, 28, 81–92. [Google Scholar]
  107. Abuznait, A.H.; Qosa, H.; Busnena, B.A.; El Sayed, K.A.; Kaddoumi, A. Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer’s disease: In vitro and in vivo studies. ACS Chem. Neurosci. 2013, 4, 973–982. [Google Scholar] [CrossRef] [PubMed]
  108. Corona, G.; Tzounis, X.; Dessì, M.A.; Deiana, M.; Debnam, E.S.; Visioli, F.; Spencer, J.P.E. The fate of olive oil polyphenols in the gastrointestinal tract: Implications of gastric and colonic microflora-dependent biotransformation. Free Radic. Res. 2006, 40, 647–658. [Google Scholar] [CrossRef] [PubMed]
  109. Caesar, R.; Fak, F.; Backhed, F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J. Intern. Med. 2010, 268, 320–328. [Google Scholar] [CrossRef]
  110. Landete, J.M.; Curiel, J.A.; Rodríguez, H.; de las Rivas, B.; Muñoz, R. Study of the inhibitory activity of phenolic compounds found in olive products and their degradation by Lactobacillus plantarum strains. Food Chem. 2008, 107, 320–326. [Google Scholar] [CrossRef] [Green Version]
  111. Dierkes, G.; Krieger, S.; Dück, R.; Bongartz, A.; Schmitz, O.J.; Hayen, H. High-performance liquid chromatography-mass spectrometry profiling of phenolic compounds for evaluation of olive oil bitterness and pungency. J. Agric. Food Chem. 2012, 60, 7597–7606. [Google Scholar] [CrossRef] [PubMed]
  112. Bendini, A.; Cerretani, L.; Salvador, M.D.; Fregapane, G.; Lercker, G. Stability of the sensory quality of virgin olive oil during storage: An overview. Ital. J. Food Sci. 2009, 21, 389–406. [Google Scholar]
  113. Inarejos-García, A.M.; Santacatterina, M.; Salvador, M.D.; Fregapane, G.; Gómez-Alonso, S. PDO virgin olive oil quality—Minor components and organoleptic evaluation. Food Res. Int. 2010, 43, 2138–2146. [Google Scholar] [CrossRef]
  114. Inarejos-García, A.M.; Gómez-Alonso, S.; Fregapane, G.; Salvador, M.D. Evaluation of minor components, sensory characteristics and quality of virgin olive oil by near infrared (NIR) spectroscopy. Food Res. Int. 2013, 50, 250–258. [Google Scholar] [CrossRef]
  115. García, J.M.; Yousfi, K.; Mateos, R.; Olmo, M.; Cert, A. Reduction of oil bitterness by heating of olive (Olea europaea) fruits. J. Agric. Food Chem. 2001, 49, 4231–4235. [Google Scholar] [CrossRef]
  116. Kiritsakis, A.K. Flavor components of olive oil. J. Am. Oil Chem. Soc. 1998, 75, 673–681. [Google Scholar] [CrossRef]
  117. Tovar, M.J.; Motilva, M.J.; Romero, M.P. Changes in the phenolic composition of virgin olive oil from young trees (Olea europaea L. cv. Arbequina) grown under linear irrigation strategies. J. Agric. Food Chem. 2001, 49, 5502–5508. [Google Scholar] [CrossRef]
  118. Gutiérrez Rosales, F.; Rios, J.J.; Gomez-Rey, M.L. Main polyphenols in the bitter taste of virgin olive oil. Structural confirmation by on-line high-performance liquid chromatography electrospray ionization mass spectrometry. J. Agric. Food Chem. 2003, 51, 6021–6025. [Google Scholar] [CrossRef]
  119. Andrewes, P.; Busch, J.L.; de Joode, T.; Groenewegen, A.; Alexandre, H. Sensory properties of virgin olive oil polyphenols: Identification of deacetoxy-ligstroside aglycon as a key contributor to pungency. J. Agric. Food Chem. 2003, 51, 1415–1420. [Google Scholar] [CrossRef]
  120. Peyrot Des Gachons, C.; Uchida, K.; Bryant, B.; Shima, A.; Sperry, J.B.; Dankulich-Nagrudny, L.; Tominaga, M.; Smith, A.B.; Beauchamp, G.K.; Breslin, P.A. Unusual pungency from Extra-Virgin Olive Oil is attributable to restricted spatial expression of the receptor of oleocanthal. J. Neurosci. 2011, 31, 999–1009. [Google Scholar] [CrossRef]
  121. Hayes, J.E.; Wallace, M.R.; Knopik, V.S.; Herbstman, D.M.; Bartoshuk, L.M.; Duffy, V.B. Allelic variation in TAS2R bitter receptor genes associates with variation in sensations from and ingestive behaviors toward common bitter beverages in adults. Chem. Senses 2011, 36, 311–319. [Google Scholar] [CrossRef]
  122. Cicerale, S.; Conlan, X.A.; Barnett, N.W.; Keast, R.S.J. Storage of Extra Virgin Olive Oil and its effect on the biological activity and concentration of oleocanthal. Food Res. Int. 2013, 50, 597–602. [Google Scholar] [CrossRef]

Share and Cite

MDPI and ACS Style

Servili, M.; Sordini, B.; Esposto, S.; Urbani, S.; Veneziani, G.; Di Maio, I.; Selvaggini, R.; Taticchi, A. Biological Activities of Phenolic Compounds of Extra Virgin Olive Oil. Antioxidants 2014, 3, 1-23.

AMA Style

Servili M, Sordini B, Esposto S, Urbani S, Veneziani G, Di Maio I, Selvaggini R, Taticchi A. Biological Activities of Phenolic Compounds of Extra Virgin Olive Oil. Antioxidants. 2014; 3(1):1-23.

Chicago/Turabian Style

Servili, Maurizio, Beatrice Sordini, Sonia Esposto, Stefania Urbani, Gianluca Veneziani, Ilona Di Maio, Roberto Selvaggini, and Agnese Taticchi. 2014. "Biological Activities of Phenolic Compounds of Extra Virgin Olive Oil" Antioxidants 3, no. 1: 1-23.

Article Metrics

Back to TopTop